Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler<sup>®</sup> Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler<sup>®</sup> Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study

Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory lung disease characterized by airflow limitation that is not completely reversible. The fixed-dose combination of salmeterol and fluticasone propionate (SFC) has been approved as a treatment for COPD patients with a history...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paschalis Steiropoulos, Stavros Tryfon, Christos Kyriakopoulos, Konstantinos Bartziokas, Konstantinos Kostikas
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
COPD
FEV<sub>1</sub>
mMRC
salmeterol and fluticasone propionate fixed-dose combination
safety analysis
Medicine
R
Accès en ligne:https://doaj.org/article/b8b43807233243a88f917652da79365e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b8b43807233243a88f917652da79365e

Documents similaires